Evidence check: Stuhlprobe in the context of Wechseljahre

Stool testing (microbiome analysis) is increasingly marketed in the context of menopause, often claiming links between gut bacteria and hormone regulation. The scientific evidence is still limited. While the 'estrobolome' concept suggests gut microbes can influence estrogen metabolism, robust clinical data linking stool test results to menopausal symptoms (e.g., hot flashes, mood changes) are lacking. Most studies are small, correlational, or mechanistic. A stool test cannot diagnose menopause or replace hormone level measurements. At best, it provides exploratory data that require cautious interpretation by a healthcare professional. The evidence level is primarily marketing-driven; no major guidelines recommend routine stool testing for menopause management. Consumers should be aware of these limitations and avoid making health decisions based solely on such tests.